Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hickling

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Journal of Clinical Pathology|March 26, 2005
Candida albicans peritonitis in a patient with Felty's syndromeD W Thomas, P Munuswamy, K Adu-Poku, et al.
Journal of Virology|February 16, 2007
Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor bindingJ Billington, T P Hickling, G H Munro, et al.
Scientific Reports|January 14, 2021
Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cellsA Casasola-LaMacchia, M S Ritorto, R J Seward, et al.
Journal of Viral Hepatitis|January 29, 2008
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV diseaseM R B Hamed, A W Tarr, C P McClure, et al.
Journal Francais D'Ophtalmologie|May 9, 2007
Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren's syndromeA Spiteri, M Mitra, G Menon, et al.
Journal for Immunotherapy of Cancer|April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeuticsJasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Frontiers in Immunology|January 28, 2026
T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity PlatformSophie Tourdot, Anette Christine Karle, Marc Rosenbaum, et al.
Biology|September 28, 2023
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell EpitopesKatharina Hartman, Guido Steiner, Michel Siegel, et al.
The Journal of General Virology|October 20, 2007
Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33Alexander W Tarr, Ania M Owsianka, Dhanya Jayaraj, et al.
BMC Systems Biology|October 1, 2013
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset modelsSirus Palsson, Timothy P Hickling, Erica L Bradshaw-Pierce, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Journal of Clinical Pathology|March 26, 2005
Candida albicans peritonitis in a patient with Felty's syndromeD W Thomas, P Munuswamy, K Adu-Poku, et al.
Journal of Virology|February 16, 2007
Stability of a receptor-binding active human immunodeficiency virus type 1 recombinant gp140 trimer conferred by intermonomer disulfide bonding of the V3 loop: differential effects of protein disulfide isomerase on CD4 and coreceptor bindingJ Billington, T P Hickling, G H Munro, et al.
Scientific Reports|January 14, 2021
Human leukocyte antigen class II quantification by targeted mass spectrometry in dendritic-like cell lines and monocyte-derived dendritic cellsA Casasola-LaMacchia, M S Ritorto, R J Seward, et al.
Journal of Viral Hepatitis|January 29, 2008
Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV diseaseM R B Hamed, A W Tarr, C P McClure, et al.
Journal Francais D'Ophtalmologie|May 9, 2007
Tear lipid layer thickness and ocular comfort with a novel device in dry eye patients with and without Sjögren's syndromeA Spiteri, M Mitra, G Menon, et al.
Journal for Immunotherapy of Cancer|April 18, 2019
Immunogenicity of immunomodulatory, antibody-based, oncology therapeuticsJasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, et al.
Frontiers in Immunology|January 28, 2026
T cell assays for non-clinical immunogenicity risk assessment: best practices recommended by the European Immunogenicity PlatformSophie Tourdot, Anette Christine Karle, Marc Rosenbaum, et al.
Biology|September 28, 2023
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell EpitopesKatharina Hartman, Guido Steiner, Michel Siegel, et al.
The Journal of General Virology|October 20, 2007
Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33Alexander W Tarr, Ania M Owsianka, Dhanya Jayaraj, et al.
BMC Systems Biology|October 1, 2013
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset modelsSirus Palsson, Timothy P Hickling, Erica L Bradshaw-Pierce, et al.
Pageof 10